Insider Transactions in Q1 2023 at Biomarin Pharmaceutical Inc (BMRN)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2023
|
Brian Mueller EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,973
-6.67%
|
$369,489
$93.41 P/Share
|
|
Mar 16
2023
|
Henry J Fuchs President, Worldwide R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
36,000
-16.06%
|
$3,348,000
$93.41 P/Share
|
|
Mar 16
2023
|
George Eric Davis EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,957
-19.89%
|
$1,856,001
$93.41 P/Share
|
|
Mar 16
2023
|
Jean Jacques Bienaime Director |
SELL
Payment of exercise price or tax liability
|
Direct |
88,623
-17.22%
|
$8,241,939
$93.41 P/Share
|
|
Mar 16
2023
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,510
-23.85%
|
$1,907,430
$93.41 P/Share
|
|
Mar 15
2023
|
Charles Greg Guyer EVP, Chief Technical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,856
-3.62%
|
$161,472
$87.74 P/Share
|
|
Mar 15
2023
|
Charles Greg Guyer EVP, Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,900
+14.78%
|
-
|
|
Mar 15
2023
|
Brian Mueller EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,708
-4.35%
|
$235,596
$87.74 P/Share
|
|
Mar 15
2023
|
Brian Mueller EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,630
+13.39%
|
-
|
|
Mar 15
2023
|
Henry J Fuchs President, Worldwide R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
4,799
-2.1%
|
$417,513
$87.74 P/Share
|
|
Mar 15
2023
|
Henry J Fuchs President, Worldwide R&D |
BUY
Grant, award, or other acquisition
|
Direct |
16,840
+6.85%
|
-
|
|
Mar 15
2023
|
George Eric Davis EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,025
-2.93%
|
$263,175
$87.74 P/Share
|
|
Mar 15
2023
|
George Eric Davis EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,900
+7.93%
|
-
|
|
Mar 15
2023
|
Erin Burkhart GVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,760
+20.16%
|
-
|
|
Mar 15
2023
|
Jean Jacques Bienaime Director |
SELL
Payment of exercise price or tax liability
|
Direct |
9,437
-1.8%
|
$821,019
$87.74 P/Share
|
|
Mar 15
2023
|
Jean Jacques Bienaime Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,100
+6.45%
|
-
|
|
Mar 15
2023
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,971
-4.41%
|
$345,477
$87.74 P/Share
|
|
Mar 15
2023
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,110
+10.1%
|
-
|
|
Mar 13
2023
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
8,000
-1.61%
|
$720,000
$90.45 P/Share
|
|
Mar 13
2023
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+1.59%
|
$536,000
$67.81 P/Share
|
|
Mar 10
2023
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
15,000
-2.98%
|
$1,380,000
$92.28 P/Share
|
|
Mar 10
2023
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+2.9%
|
$1,005,000
$67.81 P/Share
|
|
Feb 28
2023
|
George Eric Davis EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,724
+12.83%
|
-
|
|
Feb 28
2023
|
Brian Mueller EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,890
+14.59%
|
-
|
|
Feb 28
2023
|
Jean Jacques Bienaime Director |
BUY
Grant, award, or other acquisition
|
Direct |
167,532
+11.09%
|
-
|
|
Feb 28
2023
|
Henry J Fuchs President, Worldwide R&D |
BUY
Grant, award, or other acquisition
|
Direct |
68,052
+10.38%
|
-
|
|
Feb 28
2023
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,769
+15.47%
|
-
|
|
Feb 24
2023
|
George Eric Davis EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,474
+2.53%
|
$98,758
$67.81 P/Share
|
|
Feb 13
2023
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
6,000
-1.84%
|
$654,000
$109.15 P/Share
|
|
Feb 13
2023
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+1.81%
|
$402,000
$67.81 P/Share
|
|
Feb 10
2023
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
15,000
-4.47%
|
$1,650,000
$110.11 P/Share
|
|
Feb 10
2023
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+4.28%
|
$1,005,000
$67.81 P/Share
|
|
Feb 07
2023
|
Jean Jacques Bienaime Director |
BUY
Bona fide gift
|
Indirect |
200
+50.0%
|
-
|
|
Feb 07
2023
|
Jean Jacques Bienaime Director |
SELL
Bona fide gift
|
Indirect |
200
-0.08%
|
-
|
|
Jan 25
2023
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
49,000
-29.49%
|
$5,635,000
$115.9 P/Share
|
|
Jan 25
2023
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
49,000
+35.23%
|
$3,283,000
$67.81 P/Share
|
|
Jan 17
2023
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
10,000
-3.03%
|
$1,110,000
$111.55 P/Share
|
|
Jan 17
2023
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.94%
|
$670,000
$67.81 P/Share
|
|
Jan 13
2023
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
10,000
-3.03%
|
$1,120,000
$112.25 P/Share
|
|
Jan 13
2023
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.94%
|
$670,000
$67.81 P/Share
|
|
Jan 13
2023
|
Brian Mueller EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-8.27%
|
$285,000
$114.5 P/Share
|
|
Jan 13
2023
|
Brian Mueller EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+7.63%
|
$157,500
$63.1 P/Share
|